Pharmacological OGG1 inhibition decreases murine allergic airway inflammation
Background and aim: Allergic asthma is a complex inflammatory disease involving type 2 innate lymphoid cells, type 2 T helper cells, macrophages, and eosinophils. The disease is characterized by wheezing, dyspnea, coughing, chest tightness and variable airflow limitation for which there is no cure a...
Main Authors: | Lloyd Tanner, Jesper Bergwik, Ravi K. V. Bhongir, Lang Pan, Caijuan Dong, Olov Wallner, Christina Kalderén, Thomas Helleday, Istvan Boldogh, Mikael Adner, Arne Egesten |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.999180/full |
Similar Items
-
OGG1 Inhibitor TH5487 Alters OGG1 Chromatin Dynamics and Prevents Incisions
by: Bishoy M. F. Hanna, et al.
Published: (2020-10-01) -
NEIL1 and NEIL2 Are Recruited as Potential Backup for OGG1 upon OGG1 Depletion or Inhibition by TH5487
by: Bishoy M. F. Hanna, et al.
Published: (2021-04-01) -
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer
by: Spiros Vlahopoulos, et al.
Published: (2023-12-01) -
OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
by: Juan Miguel Baquero, et al.
Published: (2022-05-01) -
Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury
by: Lang Pan, et al.
Published: (2023-08-01)